T-Cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway

Journal of Molecular Biology

Volumn 410, Issue 5, 2011, Pages 896-916

  Kim, Young Kyeung ^a   Mbonye, Uri ^a   Hokello, Joseph ^a   Karn, Jonathan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ERK signaling; HIV latency; HIV transcription; P TEFb; T cell receptor signaling

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; CYCLOSPORIN; HEXAMETHYLENEBISACETAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; PROTEIN KINASE B INHIBITOR; RNA POLYMERASE II; SMALL NUCLEAR RIBONUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR RELA;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; GEL FILTRATION CHROMATOGRAPHY; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVIRUS; SIGNAL TRANSDUCTION; VIRUS REACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79960342414     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2011.03.054     Document Type: Article

References (69)

1. Pierson T.; McArthur J.; and Siliciano R.F. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy Annu. Rev. Immunol. 18 2000 665 708 (Pubitemid 30365394)
2. Coiras M.; Lopez-Huertas M.R.; Perez-Olmeda M.; and Alcami J. Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs Nat. Rev. Microbiol. 7 2009 798 812
3. Alexaki A.; Liu Y.; and Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence Curr. HIV Res. 6 2008 388 400
4. Chun T.W.; Davey R.T. Jr.; Engel D.; Lane H.C.; and Fauci A.S. Re-emergence of HIV after stopping therapy Nature 401 1999 874 875 (Pubitemid 129516777)
5. Davey R.T. Jr.; Bhat N.; Yoder C.; Chun T.W.; Metcalf J.A.; and Dewar R. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Proc. Natl Acad. Sci. USA 96 1999 15109 15114 (Pubitemid 30019773)
6. Fischer M.; Hafner R.; Schneider C.; Trkola A.; Joos B.; and Joller H. HIV RNA in plasma rebounds within days during structured treatment interruptions AIDS 17 2003 195 199 (Pubitemid 36183045)
7. Dinoso J.B.; Kim S.Y.; Wiegand A.M.; Palmer S.E.; Gange S.J.; and Cranmer L. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy Proc. Natl Acad. Sci. USA 106 2009 9403 9408
8. Richman D.D.; Margolis D.M.; Delaney M.; Greene W.C.; Hazuda D.; and Pomerantz R.J. The challenge of finding a cure for HIV infection Science 323 2009 1304 1307
9. Shen L.; and Siliciano R.F. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection J. Allergy Clin. Immunol 122 2008 22 28 (Pubitemid 351899083)
10. Trono D.; Van Lint C.; Rouzioux C.; Verdin E.; Barre-Sinoussi F.; Chun T.W.; and Chomont N. HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals Science 329 2010 174 180
11. Peterlin B.M.; and Price D.H. Controlling the elongation phase of transcription with P-TEFb Mol. Cell 23 2006 297 305 (Pubitemid 44128850)
12. Karn J. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit Curr. Opin. HIV AIDS 6 2011 4 11
13. Singh A.; and Weinberger L.S. Stochastic gene expression as a molecular switch for viral latency Curr. Opin. Microbiol. 12 2009 460 466
14. Wei P.; Garber M.E.; Fang S.M.; Fischer W.H.; and Jones K.A. A novel cdk9-associated c-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop specific binding to TAR RNA Cell 92 1998 451 462 (Pubitemid 28101109)
15. Fujinaga K.; Irwin D.; Huang Y.; Taube R.; Kurosu T.; and Peterlin B.M. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element Mol. Cell. Biol. 24 2004 787 795 (Pubitemid 38057929)
16. Kim Y.K.; Bourgeois C.F.; Isel C.; Churcher M.J.; and Karn J. Phosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongation Mol. Cell. Biol. 22 2002 4622 4637 (Pubitemid 34620399)
17. Bourgeois C.F.; Kim Y.K.; Churcher M.J.; West M.J.; and Karn J. Spt5 cooperates with Tat by preventing premature RNA release at terminator sequences Mol. Cell. Biol. 22 2002 1079 1093 (Pubitemid 34094845)
18. Ivanov D.; Kwak Y.T.; Guo J.; and Gaynor R.B. Domains in the SPT5 protein that modulate its transcriptional regulatory properties Mol. Cell. Biol. 20 2000 2970 2983 (Pubitemid 30215010)
19. Weinberger L.S.; Burnett J.C.; Toettcher J.E.; Arkin A.P.; and Schaffer D.V. Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity Cell 122 2005 169 182 (Pubitemid 41032982)
20. Weinberger L.S.; Dar R.D.; and Simpson M.L. Transient-mediated fate determination in a transcriptional circuit of HIV Nat. Genet. 40 2008 466 470 (Pubitemid 351450884)
21. Keedy K.S.; Archin N.M.; Gates A.T.; Espeseth A.; Hazuda D.J.; and Margolis D.M. A limited group of class I histone deacetylases act to repress human immunodeficiency virus type-1 expression J. Virol. 83 2009 4749 4756
22. Williams S.A.; Chen L.F.; Kwon H.; Ruiz-Jarabo C.M.; Verdin E.; and Greene W.C. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation EMBO J. 25 2006 139 149 (Pubitemid 43077303)
23. Tyagi M.; and Karn J. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency EMBO J. 26 2007 4985 4995 (Pubitemid 350261291)
24. + cells is due to epigenetic transcriptional silencing and P-TEFb restriction J. Virol. 84 2010 6425 6437
25. Pearson R.; Kim Y.K.; Hokello J.; Lassen K.; Friedman J.; Tyagi M.; and Karn J. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency J. Virol. 82 2008 12291 12303
26. du Chene I.; Basyuk E.; Lin Y.L.; Triboulet R.; Knezevich A.; and Chable-Bessia C. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency EMBO J. 26 2007 424 435 (Pubitemid 46160943)
27. Marban C.; Suzanne S.; Dequiedt F.; de Walque S.; Redel L.; and Van Lint C. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing EMBO J. 26 2007 412 423 (Pubitemid 46160942)
28. Blazkova J.; Trejbalova K.; Gondois-Rey F.; Halfon P.; Philibert P.; and Guiguen A. CpG methylation controls reactivation of HIV from latency PLoS Pathog. 5 2009 e1000554
29. Kauder S.E.; Bosque A.; Lindqvist A.; Planelles V.; and Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation PLoS Pathog. 5 2009 e1000495
30. Han Y.; Lin Y.B.; An W.; Xu J.; Yang H.C.; and O'Connell K. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough Cell Host Microbe 4 2008 134 146
31. Lenasi T.; Contreras X.; and Peterlin B.M. Transcriptional interference antagonizes proviral gene expression to promote HIV latency Cell Host Microbe 4 2008 123 133
32. Duverger A.; Jones J.; May J.; Bibollet-Ruche F.; Wagner F.A.; Cron R.Q.; and Kutsch O. Determinants of the establishment of human immunodeficiency virus type 1 latency J. Virol. 83 2009 3078 3093
33. Williams S.A.; Kwon H.; Chen L.F.; and Greene W.C. Sustained induction of NF-kappaB is required for efficient expression of latent human immunodeficiency virus type 1 J. Virol. 81 2007 6043 6056 (Pubitemid 46847040)
34. + T cells Blood 113 2008 58 65
35. Nabel G.; and Baltimore D.A. An inducible transcription factor activates expression of human immunodeficiency virus in T cells Nature 326 1987 711 713 (Pubitemid 17059793)
36. Kinoshita S.; Su L.; Amano M.; Timmerman L.A.; Kaneshima H.; and Nolan G.P. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells Immunity 6 1997 235 244 (Pubitemid 27148590)
37. Nguyen V.T.; Kiss T.; Michels A.A.; and Bensaude O. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes Nature 414 2001 322 325 (Pubitemid 33097810)
38. Yang Z.; Zhu Q.; Luo K.; and Zhou Q. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription Nature 414 2001 317 322 (Pubitemid 33097809)
39. Yik J.H.; Chen R.; Nishimura R.; Jennings J.L.; Link A.J.; and Zhou Q. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA Mol. Cell 12 2003 971 982 (Pubitemid 37352789)
40. Michels A.A.; Fraldi A.; Li Q.; Adamson T.E.; Bonnet F.; and Nguyen V.T. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor EMBO J. 23 2004 2608 2619 (Pubitemid 38988232)
41. He N.; Jahchan N.S.; Hong E.; Li Q.; Bayfield M.A.; and Maraia R.J. A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis Mol. Cell 29 2008 588 599
42. Krueger B.J.; Jeronimo C.; Roy B.B.; Bouchard A.; Barrandon C.; and Byers S.A. LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated Nucleic Acids Res. 36 2008 2219 2229 (Pubitemid 351566996)
43. Jeronimo C.; Forget D.; Bouchard A.; Li Q.; Chua G.; and Poitras C. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme Mol. Cell 27 2007 262 274 (Pubitemid 47058308)
44. Barboric M.; Yik J.H.; Czudnochowski N.; Yang Z.; Chen R.; and Contreras X. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription Nucleic Acids Res. 35 2007 2003 2012 (Pubitemid 47061666)
45. Sedore S.C.; Byers S.A.; Biglione S.; Price J.P.; Maury W.J.; and Price D.H. Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR Nucleic Acids Res. 35 2007 4347 4358 (Pubitemid 47244588)
46. Krueger B.J.; Varzavand K.; Cooper J.J.; and Price D.H. The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK PLoS One 5 2010 e12335
47. Ramakrishnan R.; Dow E.C.; and Rice A.P. Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes J. Leukocyte Biol. 86 2009 1345 1350
48. Dow E.C.; Liu H.; and Rice A.P. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes J. Cell. Physiol. 224 2010 84 93
49. Sung T.L.; and Rice A.P. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1 PLoS Pathog. 5 2009 e1000263
50. Kim Y.K.; Bourgeois C.F.; Pearson R.; Tyagi M.; West M.J.; and Wong J. Recruitment of TFIIH to the HIV LTR is a rate-limiting step in the emergence of HIV from latency EMBO J. 25 2006 3596 3604 (Pubitemid 44264870)
51. Meredith L.W.; Sivakumaran H.; Major L.; Suhrbier A.; and Harrich D. Potent inhibition of HIV-1 replication by a Tat mutant PLoS One 4 2009 e7769
52. Guan K.L.; Figueroa C.; Brtva T.R.; Zhu T.; Taylor J.; Barber T.D.; and Vojtek A.B. Negative regulation of the serine/threonine kinase B-Raf by Akt J. Biol. Chem. 275 2000 27354 27359
53. Zimmermann S.; and Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B) Science 286 1999 1741 1744 (Pubitemid 129515882)
54. 2+ signaling Genes Dev. 22 2008 1356 1368 (Pubitemid 351717526)
55. Pereira L.A.; Bentley K.; Peeters A.; Churchill M.J.; and Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter Nucleic Acids Res. 28 2000 663 668 (Pubitemid 30068248)
56. Chen-Park F.E.; Huang D.B.; Noro B.; Thanos D.; and Ghosh G. The κB DNA sequence from the HIV long terminal repeat functions as an allosteric regulator of HIV transcription J. Biol. Chem. 277 2002 24701 24708 (Pubitemid 34952001)
57. Giffin M.J.; Stroud J.C.; Bates D.L.; von Koenig K.D.; Hardin J.; and Chen L. Structure of NFAT1 bound as a dimer to the HIV-1 LTR κB element Nat. Struct. Biol. 10 2003 800 806 (Pubitemid 37187650)
58. Natarajan M.; August A.; and Henderson A.J. Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells J. Biol. Chem. 285 2010 17338 17347
59. Fujita T.; Ryser S.; Piuz I.; and Schlegel W. Up-regulation of P-TEFb by the MEK1-ERK signaling pathway contributes to stimulated transcription elongation of immediate early genes in neuroendocrine cells Mol. Cell. Biol. 28 2008 1630 1643
60. Contreras X.; Barboric M.; Lenasi T.; and Peterlin B.M. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription PLoS Pathog. 3 2007 1459 1469 (Pubitemid 350085610)
61. Choudhary S.K.; Archin N.M.; and Margolis D.M. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells J. Infect. Dis. 197 2008 1162 1170 (Pubitemid 351590052)
62. Hargreaves D.C.; Horng T.; and Medzhitov R. Control of inducible gene expression by signal-dependent transcriptional elongation Cell 138 2009 129 145
63. Savarino A.; Mai A.; Norelli S.; El Daker S.; Valente S.; and Rotili D. "Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence Retrovirology 6 2009 52
64. Bowman M.C.; Archin N.M.; and Margolis D.M. Pharmaceutical approaches to eradication of persistent HIV infection Expert Rev. Mol. Med. 11 2009 e6
65. Archin N.M.; Espeseth A.; Parker D.; Cheema M.; Hazuda D.; and Margolis D.M. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid AIDS Res. Hum. Retroviruses 25 2009 207 212
66. Contreras X.; Schweneker M.; Chen C.S.; McCune J.M.; Deeks S.G.; Martin J.; and Peterlin B.M. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells J. Biol. Chem. 284 2009 6782 6789
67. Williams S.A.; Chen L.F.; Kwon H.; Fenard D.; Bisgrove D.; Verdin E.; and Greene W.C. Prostratin antagonizes HIV latency by activating NF-kappaB J. Biol. Chem. 279 2004 42008 42017 (Pubitemid 39313652)
68. Yang H.C.; Xing S.; Shan L.; O'Connell K.; Dinoso J.; and Shen A. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation J. Clin. Invest. 119 2009 3473 3486
69. Hoffmann A.; Levchenko A.; Scott M.L.; and Baltimore D. The IκB-NF-κB signaling module: temporal control and selective gene activation Science 298 2002 1241 1245 (Pubitemid 35285493)